ABSTRACT
Per- and polyfluoroalkyl substances (PFAS) are organic chemicals with wide industrial and consumer uses. They are found ubiquitously at low levels in the environment and are detectable in humans and wildlife. Perfluorobutane Sulfonate (PFBS) is a short-chained PFAS used to replace perfluorooctane sulfonate in commerce. In general, the rate of clearance for the short-chained PFAS is faster than that for the long-chained congeners. This study evaluated the pharmacokinetic properties of PFBS and its hepatic transcriptional responses in CD-1 mice. Males and females were given PFBS by oral gavage at 30 or 300 mg/kg; controls received 0.5 % Tween-20 vehicle. Trunk blood was collected at 0.5, 1, 2, 4, 8, 16 and 24 h thereafter; liver and kidney were also harvested. Serum and tissue concentrations of PFBS were determined by HPLC-MS-MS. Expression of several hepatic nuclear receptor target genes was determined by qPCR. The half-life of PFBS was estimated as 5.8 h in the males and 4.5 h in the females. Tmax was reached within 1-2 h. Volume of distribution was similar between the two sexes (0.32-0.40 L/kg). The rate of PFBS clearance was linear with exposure doses. Within 24 h, serum PFBS declined to less than 5 % of Cmax. PFBS was detected in liver or kidney, although tissue levels of the chemical were only a fraction of those in serum. At 24 h after administration of 300 mg/kg PFBS, elevated expression of several hepatic genes targeted for PPARα, PPARy, and PXR but not by AhR, LXR or CAR was observed, with responses indistinguishable between males and females. Little to no transcriptional response was seen with the 30 mg/kg dose. The short serum half-lives of PFBS (4-5 h) in mice were comparable to those reported in rats. Although detection of PFBS in liver was low compared to that in serum even at the 300 mg/kg dose, the tissue level was sufficient to activate several hepatic nuclear receptors, which may represent an acute response to the chemical at a high dose.
Subject(s)
Fluorocarbons/pharmacokinetics , Liver/drug effects , Receptors, Cytoplasmic and Nuclear/drug effects , Sulfonic Acids/pharmacokinetics , Animals , Dose-Response Relationship, Drug , Female , Half-Life , Kidney/drug effects , Kidney/metabolism , Liver/metabolism , Male , Metabolic Clearance Rate , Mice , Polymerase Chain Reaction , Receptors, Cytoplasmic and Nuclear/metabolism , Sex Factors , Transcriptome/drug effectsABSTRACT
The excess from fecal samples submitted to a centralized laboratory in Roanoke, Virginia for routine C. difficile testing was used for this research study. We tested all samples, including any formed samples usually not assayed in diagnostic laboratories. Our first aim was to rank ribotypes by their frequency. Between 2007 and 2013, fluoroquinolone resistant 027 (027FQR), a multi-drug resistant ribotype, was 32% of 3118 Clostridium difficile isolates and the most common of 128 ribotypes. 027FQR was in 45% of cytotoxin positive but only 17% of cytotoxin negative fecal samples (pâ¯=â¯0.001) and 34% of unformed but only 21% of formed stool samples (pâ¯=â¯0.001), strong associations with features of symptomatic infection. Conversely, 014/020 (10% of isolates, third most common ribotype) was more often in unformed than formed stools (14% versus 9%; pâ¯=â¯0.002) and in cytotoxin negative than cytotoxin positive samples (11% versus 8%, pâ¯=â¯0.01). Fecal lactoferrin levels, an indication of intestinal inflammation, were significantly higher with 027FQR than with 014/020 infections (median 308 versus 26â¯ng/mL, pâ¯=â¯0.02). 027FQR fecal bioburdens and toxin levels were significantly higher than their 014/020 equivalents (median 104.1 versus 103.2/g feces, pâ¯=â¯0.01; median TcdA 58.7 versus 1.3â¯ng/g feces, pâ¯=â¯0.04; median TcdB 43.4 versus 0.3â¯ng/g feces, pâ¯=â¯0.001). Binary toxin was present in 40% of 027FQR positive samples but none of the 014/020 or non-toxigenic C. difficile positive samples. 027FQR made no more TcdA/cell than did 014/020 (pâ¯=â¯0.7) but did make close to significantly more TcdB/cell (pâ¯=â¯0.08).
Subject(s)
Anti-Bacterial Agents/pharmacology , Clostridioides difficile/drug effects , Clostridioides difficile/isolation & purification , Drug Resistance, Multiple, Bacterial , Bacterial Toxins/analysis , Bacterial Toxins/metabolism , Clostridioides difficile/classification , Clostridioides difficile/genetics , Feces/microbiology , Humans , Ribotyping , VirginiaABSTRACT
In a 1-year survey at a university hospital we found that 20·6% (81/392) of patients with antibiotic associated diarrohea where positive for C. difficile. The most common PCR ribotypes were 012 (14·8%), 027 (12·3%), 046 (12·3%) and 014/020 (9·9). The incidence rate was 2·6 cases of C. difficile infection for every 1000 outpatients.
Subject(s)
Clostridioides difficile/genetics , Cross Infection/epidemiology , Enterocolitis, Pseudomembranous/epidemiology , Hospitals, University , Tertiary Care Centers , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Chile/epidemiology , Clostridioides difficile/drug effects , Clostridioides difficile/isolation & purification , Cross Infection/drug therapy , Cross Infection/microbiology , Enterocolitis, Pseudomembranous/drug therapy , Enterocolitis, Pseudomembranous/microbiology , Humans , Incidence , Middle Aged , Polymerase Chain Reaction , RibotypingABSTRACT
Intestinal inflammation was evaluated using faecal lactoferrin and ribotype in 196 hospitalized adults with Clostridium difficile infection to determine the impact of ribotype 027 in long-term care facilities (LTCFs). LTCF residents (n=28) had greater antibiotic use (P=0.049) and more ribotype 027 infection [odds ratio (OR): 4.87; 95% confidence interval (CI): 2.02-11.74; P<0.01], compared to those admitted from home. Patients infected with ribotype 027 strains had worse six-month mortality (OR: 1.90; 95% CI: 1.08-3.34; P=0.03) and more inflammation (95.26 vs 36.08 µg/mL; P=0.006), compared to those infected with non-027 strains. This study was not designed to determine acquisition site, but, in this population, suggests that the location from which the patient has been admitted is strongly associated with ribotype 027 and more severe C. difficile disease.
Subject(s)
Clostridioides difficile/classification , Clostridioides difficile/isolation & purification , Enterocolitis, Pseudomembranous/epidemiology , Inpatients , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Cross Infection/epidemiology , Cross Infection/microbiology , Drug Resistance, Bacterial , Enterocolitis, Pseudomembranous/microbiology , Feces/microbiology , Fluoroquinolones/pharmacology , Humans , Long-Term Care , Middle Aged , RibotypingABSTRACT
We evaluated clinical and diagnostic indicators of severe C. difficile infection (CDI) and their association with poor clinical outcome. A total of 210 patients positive according to PCR (toxin B: tcdB) were included, with patients having a median age of 62 years and a Charlson co-morbidity index (CI) score of 5. Ninety-one percent (n = 191) were positive by toxigenic culture and 61% (n = 129) had stool toxin. Toxin-positive patients had significantly higher fecal lactoferrin (mean 316 µg/g versus 106 µg/g stool; p < 0.0001). Forty percent of patients (n = 85) were infected with ribotype 027 and significantly more of these patients had measurable stool toxin (79% vs. 50%; p < 0.0001). The mean fecal lactoferrin was significantly higher for toxin-positive 027 CDI compared with the 027 toxin-negative group (317 vs 60 µg/g; p = 0.0014). Ribotype 027 CDI with stool toxin showed a higher all-cause, 100-day mortality compared with non-027 with stool toxin (36 % vs 18%; p = 0.017). Logistic regression univariate analysis for odds ratio (OR) and p values revealed that age (OR = 1.1), intensive care unit treatment (OR = 2.7), CI (OR = 1.2), 027 CDI (OR = 2.1), white blood cell count (OR = 1.0), albumin level (OR = 0.1), and stool toxin-positive 027 CDI (OR = 2.5) were significantly associated with 100-day mortality (p < 0.05). In conclusion, CDI PCR-positive patients with 027 infection and stool toxin have increased lactoferrin and are at an increased risk of death.
Subject(s)
Bacterial Toxins/analysis , Clostridioides difficile/isolation & purification , Clostridium Infections/mortality , Clostridium Infections/pathology , Feces/chemistry , Lactoferrin/analysis , Ribotyping , Adult , Aged , Aged, 80 and over , Clostridioides difficile/classification , Clostridioides difficile/genetics , Clostridium Infections/microbiology , Cohort Studies , Female , Humans , Male , Middle Aged , Survival AnalysisABSTRACT
We evaluated blood and fecal biomarkers as indicators of severity in symptomatic patients with confirmed Clostridium difficile infection (CDI). Recruitment included patients with CDI based on clinical symptoms and supporting laboratory findings. Disease severity was defined by physician's assessment and blood and fecal biomarkers were measured. Toxigenic culture done using spore enrichment and toxin B detected by tissue culture were done as confirmatory tests. Polymerase chain reaction (PCR) ribotyping was performed on each isolate. There were 98 patients recruited, with 85 (87%) confirmed cases of toxigenic CDI (21 severe, 57 moderate, and seven mild), of which 68 (80%) were also stool toxin-positive. Elevated lactoferrin (p = 0.01), increased white blood cell (WBC) count (p = 0.08), and low serum albumin (p = 0.03) were all associated with the more severe cases of CDI. Ribotype 027 infection accounted for 71% of severe cases (p < 0.01) and patients with stool toxin had significantly higher lactoferrin levels and WBC counts (p < 0.05). Our findings show that elevated fecal lactoferrin, along with increased WBC count and low serum albumin, were associated with more severe CDI. In addition, patients infected with ribotype 027 and those with stool toxin had significantly higher fecal lactoferrin and WBC counts.
Subject(s)
Bacterial Toxins/metabolism , Clostridioides difficile/isolation & purification , Clostridium Infections/metabolism , Lactoferrin/metabolism , Aged , Analysis of Variance , Bacterial Toxins/blood , Biomarkers/blood , Biomarkers/metabolism , Clostridium Infections/blood , Clostridium Infections/enzymology , Clostridium Infections/microbiology , Feces/chemistry , Feces/microbiology , Female , Humans , Lactoferrin/blood , Male , Middle Aged , Polymerase Chain Reaction , Ribotyping , Serum Albumin/metabolismABSTRACT
gluD was highly conserved and glutamate dehydrogenase (GDH) was readily expressed in vitro by all 77 Clostridium difficile ribotypes assayed. All ribotypes, including ARL 002, ARL 027, and ARL 106, were reactive in assays that detect C. difficile GDH.
Subject(s)
Bacterial Proteins/genetics , Clostridioides difficile/enzymology , Conserved Sequence , Glutamate Dehydrogenase/genetics , Amino Acid Sequence , Amino Acid Substitution , Bacterial Proteins/chemistry , Clostridioides difficile/genetics , Glutamate Dehydrogenase/chemistry , Ribotyping , Sequence Analysis, DNA , Sequence Analysis, ProteinABSTRACT
We evaluated Clostridium difficile prevalence rates in 2,807 clinically indicated stool specimens stratified by inpatient (IP), nursing home patient (NH), outpatient (OP), age, gender, and specimen consistency using bacterial culture, toxin detection, and polymerase chain reaction (PCR) ribotyping. Rates were determined based on the detection of toxigenic C. difficile isolates. We identified significant differences in the rates between patient populations and with age. Specimens from NH had a higher rate (46%) for toxigenic C. difficile than specimens from IP (18%) and OP (17%). There were no gender-related differences in the rates. Liquid specimens had a lower rate (15%) than partially formed and soft specimens (25%) and formed specimens (18%) for the isolation of toxigenic C. difficile. The nontoxigenic rate was lowest for NH (4%) and highest for patients<20 years of age (23%). We identified 31 different toxigenic ribotypes from a sampling of 190 isolates that showed the lowest diversity in NH. Fluoroquinolone resistance was observed in 93% of the 027 isolates, all of the 053 isolates, and in four other ribotypes. We observed different rates for toxigenic C. difficile in stratified patient populations, with the highest rate for NH, a low overall nontoxigenic rate, and fluoroquinolone resistance.
Subject(s)
Clostridioides difficile/isolation & purification , Clostridium Infections/epidemiology , Clostridium Infections/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Clostridioides difficile/classification , Clostridioides difficile/drug effects , Clostridioides difficile/genetics , Drug Resistance, Bacterial , Feces/microbiology , Female , Fluoroquinolones/pharmacology , Health Facilities , Humans , Male , Middle Aged , Prevalence , Ribotyping , Risk Factors , Sex Factors , Young AdultABSTRACT
BACKGROUND: Neuropathology of frontotemporal lobar degeneration is variable and relationship between the pathology and the clinical presentation remains uncertain. Abnormal deposits of hyperphosphorylated and ubiquitinated tau protein are present in 30% of cases, which include the classic presentation of Pick disease with argyrophilic, intraneuronal inclusions known as Pick bodies. This study aimed to improve sensitivity of clinicopathologic relations in cases with neuropathologically confirmed Pick disease and to identify clinical symptoms and signs predictive of disease progression. METHODS: This was a retrospective analysis of 21 cases with a pathologic diagnosis of Pick disease and sufficient clinical information to establish early presenting clinical features from 2 specialist centers, representing 70% of all cases of Pick disease identified between 1998 and 2007 in these centers. RESULTS: At presentation, 13/21 cases (62%) were clinically diagnosed with behavioral variant frontotemporal dementia (bvFTD) and 8/21 (38%) with language variant frontotemporal dementia (lvFTD) including 2 with mixed syndromes. Patients with bvFTD died on average 5 years earlier than those with lvFTD (7 years vs 12 years after disease onset). Pathologically, fewer Pick bodies were present in the frontal and inferior temporal cortices of bvFTD than lvFTD cases. In contrast, both groups showed decreased neuronal density in the dentate gyrus with increasing disease duration. CONCLUSIONS: The pathologic course of the disease in FTLD cases with Pick bodies is not uniform and disease duration can be estimated based on early clinical features. These findings have relevance as treatment options, which are likely to be pathology specific, are developed.
Subject(s)
Pick Disease of the Brain/diagnosis , Pick Disease of the Brain/genetics , Autopsy , Disease Progression , Frontotemporal Lobar Degeneration/diagnosis , Frontotemporal Lobar Degeneration/genetics , Humans , Phenotype , Pick Disease of the Brain/metabolism , Pick Disease of the Brain/pathology , Predictive Value of Tests , Retrospective StudiesABSTRACT
Staphylococcus aureus is a facultative, Gram-positive coccus well known for its disease-causing capabilities. In particular, methicillin and vancomycin resistant strains of S. aureus (MRSA and VRSA, respectively) isolated globally represent daunting medical challenges for the 21(st) Century. This bacterium causes numerous illnesses in humans such as food poisoning, skin infections, osteomyelitis, endocarditis, pneumonia, enterocolitis, toxic shock, and autoimmune disorders. A few of the many virulence factors attributed to S. aureus include antibiotic resistance, capsule, coagulase, lipase, hyaluronidase, protein A, fibronectin-binding protein, and multiple toxins with diverse activities. One family of protein toxins is the staphylococcal enterotoxins (SEs) and related toxic shock syndrome toxin-1 (TSST-1) that act as superantigens. There are more than twenty different SEs described to date with varying amino acid sequences, common conformations, and similar biological effects. By definition, very low (picomolar) concentrations of these superantigenic toxins activate specific T-cell subsets after binding to major histocompatibility complex class II. Activated T-cells vigorously proliferate and release proinflammatory cytokines plus chemokines that can elicit fever, hypotension, and other ailments which include a potentially lethal shock. In vitro and in vivo models are available for studying the SEs and TSST-1, thus providing important tools for understanding modes of action and subsequently countering these toxins via experimental vaccines or therapeutics. This review succinctly presents the pathogenic ways of S. aureus, with a toxic twist. There will be a particular focus upon the biological and biochemical properties of, plus current neutralization strategies targeting, staphylcoccocal superantigens like the SEs and TSST-1.
Subject(s)
Staphylococcal Infections/microbiology , Staphylococcus aureus/pathogenicity , Animals , Humans , Methicillin-Resistant Staphylococcus aureus/immunology , Methicillin-Resistant Staphylococcus aureus/pathogenicity , Staphylococcus aureus/immunology , Superantigens/biosynthesisSubject(s)
Anti-Bacterial Agents/pharmacology , Aza Compounds/pharmacology , Clostridioides difficile/drug effects , Drug Resistance, Bacterial , Feces/chemistry , Fluoroquinolones/pharmacology , Lactoferrin/metabolism , Quinolines/pharmacology , Clostridioides difficile/genetics , Clostridioides difficile/isolation & purification , Clostridium Infections/microbiology , Clostridium Infections/physiopathology , Feces/microbiology , Humans , Inflammation/physiopathology , Intestines/immunology , Intestines/microbiology , Intestines/physiopathology , Lactoferrin/analysis , Microbial Sensitivity Tests , MoxifloxacinABSTRACT
The lymphoid tissues of the red-tailed phascogale (Phascogale calura) were examined using histological and immunohistochemical techniques. The distribution of immune cells in the tissue beds was documented using antibodies to surface markers CD3 and an MHC Class II antigen (equivalent to HLA DRII). Spleen, gut-associated lymphoid tissues (GALT), lung, bronchus-associated lymphoid tissue (BALT) and liver were examined. The spleen had defined areas of red and white pulp, with follicles containing tingible-bodied macrophages. Anti-CD3 and anti-HLA DRII antibodies revealed the presence of T cells in areas of white pulp and around the peri-arterial lymphatic sheaths. GALT and BALT were detected and appeared as scattered areas of lymphocytes in the tissues beds. This is the first study to report on the lymphoid tissues of this endangered species of marsupial and the first report of the capacity of anti-human antibodies to a surface MHC molecule to react with Dasyurid cells.
Subject(s)
Immune System/anatomy & histology , Marsupialia/immunology , Animals , Intestines/immunology , Liver/blood supply , Liver/immunology , Lung/immunology , Marsupialia/anatomy & histology , Spleen/immunology , Tissue PreservationABSTRACT
Clostridium difficile causes approximately 25% of nosocomial antibiotic-associated diarrheas and most cases of pseudomembranous colitis. We evaluated C. DIFF CHEK, a new screening test that detects glutamate dehydrogenase of C. difficile. Our results showed that this test was comparable to PCR in sensitivity and specificity and outperformed bacterial culture.
Subject(s)
Clostridioides difficile/isolation & purification , Enterocolitis, Pseudomembranous/diagnosis , Feces/microbiology , Glutamate Dehydrogenase/analysis , Biomarkers/analysis , Clostridioides difficile/enzymology , Clostridioides difficile/genetics , Cross Infection/diagnosis , Cross Infection/microbiology , Cross Infection/prevention & control , Diarrhea/diagnosis , Diarrhea/microbiology , Diarrhea/prevention & control , Enterocolitis, Pseudomembranous/prevention & control , Humans , Mass Screening/methods , Polymerase Chain Reaction/methods , Sensitivity and SpecificityABSTRACT
Measurements of the distribution of organic and inorganic phosphorus in the sediment have been performed at 10 sites, in the central-northern Baltic proper. Variations in deposition environment and environmental properties, such as redox chemistry and bottom water dynamics, apparently affect the distribution by altering the supply and diagenesis of organic and inorganic phosphorus constituents. The C/P and the N/P ratios of the sediment are highly divergent (higher) from the average Redfield ratio for marine living organisms at all examined sites. This indicates preferential autolytic organic phosphorus degradation and/or (deeper down in the sediment) altered input of terrestrial organic matter. The redox condition seems to affect the degradation efficiency of the organic matter since higher concentrations of C(org) occur at anoxic conditions than at oxic. At two sites significant amounts of C(inorg) have been detected indicating authigenic precipitation of carbonates. Further, authigenic precipitation of phosphate minerals also seems to occur at certain environmental conditions.
Subject(s)
Geologic Sediments/chemistry , Phosphorus/analysis , Baltic States , Biodegradation, Environmental , Carbon/analysis , Carbon/chemistry , Environmental Monitoring , Hypoxia , Nitrogen/analysis , Nitrogen/chemistry , Oxidation-Reduction , Phosphorus/chemistry , Phosphorus/metabolism , Water MovementsSubject(s)
Anti-Bacterial Agents/adverse effects , Bacterial Toxins/analysis , Clostridioides difficile/metabolism , Clostridium perfringens/metabolism , Diarrhea/chemically induced , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Clostridioides difficile/isolation & purification , Clostridium perfringens/isolation & purification , Diarrhea/microbiology , Enterotoxins/analysis , Feces/microbiology , Female , Humans , Male , Middle Aged , Probability , Sensitivity and SpecificityABSTRACT
To study the utility of an in vitro model system for assessing the effect of low concentrations of a fluoroquinolone (FQ) drug on the ecology of the human intestinal microflora, chemostats containing human fecal flora were exposed to 0.43, 4.3, and 43microg of ciprofloxacin (CI) per milliliter. Prior to and during drug exposure, we assayed short-chain fatty acids (SCFA), bacterial populations, and the relative levels of susceptibility of these populations to CI and trovafloxacin (TV), a newer related FQ with increased activity against anaerobes. The degree to which CI affected the chemostat ecology was measured statistically by comparing observed data with the corresponding predicted "no effect" level. No changes in total SCFA were observed; only butyrate was significantly higher at the intermediate and high-dose levels. Enterococci counts and the levels of susceptibility to CI among enterococci were also unaffected. Escherichia coli counts decreased in a dose-dependent manner. Susceptibility levels in E. coli followed no interpretable pattern. Bacteroides fragilis group (BfG) counts decreased significantly following exposure to 43 and 4.3microg/mL CI. Ciprofloxacin susceptibility among the BfG in these chemostats was not determined because the BfG counts were too low (less than 30 colonies per plate) when undiluted chemostat samples were plated. However, within 2 days of exposure to 0.43microg/mL CI, the percentage of BfG resistant to 4microg/mL CI increased to over 95%. Before exposure, all BfG were susceptible to both CI (2microg/mL) and TV (0.25microg/mL). All BfG isolated during exposure were resistant to both CI (4microg/mL) and TV (2microg/mL). Resistance selection in the BfG was unexpected as the MIC(90) of CI for B. fragilis is 8microg/mL. Since the average colon flora is about 20% B. fragilis and other bacteroides, CI may impact the human gut flora even at subtherapeutic levels.
Subject(s)
Anti-Infective Agents/adverse effects , Bacteroides fragilis/physiology , Ciprofloxacin/adverse effects , Colon/microbiology , Escherichia coli/physiology , Bacteria, Anaerobic/drug effects , Bacteria, Anaerobic/physiology , Bacteroides fragilis/drug effects , Cell Culture Techniques , Colon/drug effects , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Feces/microbiology , Population DynamicsABSTRACT
The variations in concentrations of carbon and nitrogen in surface sediments of the Gulf of Riga were investigated between December 1993 and January 1995. The sediment samples were taken nine times during this period at two sampling sites. One sampling site, G5, exhibited high abundance of burrowing amphipods, whereas at the second site, T3, the number of macrozoobenthic organisms was comparatively small. Similar vertical profiles of mean sediment dry-weight concentrations of total carbon (TC) and total nitrogen (TN) were obtained at both sites G5 and T3. However, during autumn winter considerable differences of TC and TN concentrations in surface sediments (0-2 cm) between sites were observed. This was probably the effect of differences in the bioturbation level. During summer, when decline in numbers of amphipods were recorded, the vertical profiles of TC and TN at site G5 were similar to those at site T3. Significant differences between months were detected for TN at site T3 reflecting sedimentation of spring and autumn blooms in April and late October-early November, respectively. This was supported also by lower atomic C/N ratios in surface sediments during corresponding sampling events.
Subject(s)
Carbon/analysis , Environmental Monitoring/statistics & numerical data , Geologic Sediments/analysis , Geologic Sediments/chemistry , Nitrogen/analysis , Analysis of Variance , Carbon/chemistry , Latvia , Nitrogen/chemistry , SeasonsABSTRACT
Clostridium perfringens type A isolates producing enterotoxin (CPE) are an important cause of food poisoning and non-food-borne human gastrointestinal (GI) diseases, including antibiotic-associated diarrhea (AAD). Recent studies suggest that C. perfringens type A food poisoning is caused by C. perfringens isolates carrying a chromosomal cpe gene, while CPE-associated non-food-borne GI diseases, such as AAD, are caused by plasmid cpe isolates. Those putative relationships, obtained predominantly with European isolates, were tested in the current study by examining 34 cpe-positive, C. perfringens fecal isolates from North American cases of food poisoning or AAD. These North American disease isolates were all classified as type A using a multiplex PCR assay. Furthermore, restriction fragment length polymorphism and pulsed-field gel electrophoresis genotyping analyses showed the North American AAD isolates included in this collection all have a plasmid cpe gene, but the North American food poisoning isolates all carry a chromosomal cpe gene. Western blotting demonstrated CPE expression by nearly all of these disease isolates, confirming their virulence potential. These findings with North American isolates provide important new evidence that, regardless of geographic origin or date of isolation, plasmid cpe isolates cause most CPE-associated AAD cases and chromosomal cpe isolates cause most C. perfringens type A food poisoning cases. These findings hold importance for the development of assays for distinguishing cases of CPE-associated food-borne and non-food-borne human GI illnesses and also identify potential epidemiologic tools for determining the reservoirs for these illnesses.
Subject(s)
Clostridium perfringens/classification , Clostridium perfringens/genetics , Diarrhea/microbiology , Feces/microbiology , Foodborne Diseases/microbiology , Anti-Bacterial Agents/adverse effects , Blotting, Western , Chromosomes, Bacterial/genetics , Clostridium Infections/microbiology , Clostridium perfringens/isolation & purification , Diarrhea/etiology , Electrophoresis, Gel, Pulsed-Field , Enterotoxins/genetics , Enterotoxins/metabolism , Genotype , Humans , North America , Plasmids/genetics , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment LengthABSTRACT
Previous epidemiological studies have implicated Clostridium perfringens enterotoxin (CPE) as a virulence factor in the pathogenesis of several gastrointestinal (GI) illnesses caused by C. perfringens type A isolates, including C. perfringens type A food poisoning and non-food-borne GI illnesses, such as antibiotic-associated diarrhoea and sporadic diarrhoea. To further evaluate the importance of CPE in the pathogenesis of these GI diseases, allelic exchange was used to construct cpe knock-out mutants in both SM101 (a derivative of a C. perfringens type A food poisoning isolate carrying a chromosomal cpe gene) and F4969 (a C. perfringens type A non-food-borne GI disease isolate carrying a plasmid-borne cpe gene). Western blot analyses confirmed that neither cpe knock-out mutant could express CPE during either sporulation or vegetative growth, and that this lack of CPE expression could be complemented by transforming these mutants with a recombinant plasmid carrying the wild-type cpe gene. When the virulence of the wild-type, mutant and complementing strains were compared in a rabbit ileal loop model, sporulating (but not vegetative) culture lysates of the wild-type isolates induced significant ileal loop fluid accumulation and intestinal histopathological damage, but neither sporulating nor vegetative culture lysates of the cpe knock-out mutants induced these intestinal effects. However, full sporulation-associated virulence could be restored by complementing these cpe knock-out mutants with a recombinant plasmid carrying the wild-type cpe gene, which confirms that the observed loss of virulence for the cpe knock-out mutants results from the specific inactivation of the cpe gene and the resultant loss of CPE expression. Therefore, in vivo analysis of our isogenic cpe mutants indicates that CPE expression is necessary for these two cpe-positive C. perfringens type A human disease isolates to cause GI effects in the culture lysate:ileal loop model system, a finding that supports CPE as an important virulence factor in GI diseases involving cpe-positive C. perfringens type A isolates.
Subject(s)
Bacterial Toxins/genetics , Calcium-Binding Proteins , Clostridium perfringens/pathogenicity , Enterotoxins/genetics , Gastrointestinal Diseases/microbiology , Ileum/microbiology , Type C Phospholipases/genetics , Animals , Bacterial Toxins/metabolism , Blotting, Southern , Clostridium perfringens/genetics , Female , Foodborne Diseases/microbiology , Gene Expression Regulation, Bacterial , Genetic Complementation Test , Humans , Ileum/pathology , Male , Mutation , Polymerase Chain Reaction , Rabbits , Species Specificity , Type C Phospholipases/metabolism , Virulence/geneticsABSTRACT
The output power from a 25-mm-diameter (volume, 0.49 L) and a 40-mm-diameter (volume, 1.9 L) copper-vapor laser (nominally 20- and 65-W devices, respectively) was approximately doubled to >50 and >100 W , respectively, by addition of small partial pressures of both H(2) and HCl to the neon buffer gas. The specific output powers of these lasers are believed to be records for any copper-vapor lasers of this size.